Ref.: BL-RE-092223Manufacturer ref.: ESIL12AX10 10 x 96 tests
€4,815.00 excl. VAT
The interleukin 12A is a new signal cytokine belonging to the Interleukine-6 protein superfamily. The interleukin-12 alpha chain precursor (IL-12A) is a 35 kD diheterodimer subunit bound to the disulfide of...
Accession number
Q29053
Dose range
2.458 to 600 pg/ml
Sensitivity of the dosage
2.2 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
The interleukin 12A is a new signal cytokine belonging to the Interleukine-6 protein superfamily. The interleukin-12 alpha chain precursor (IL-12A) is a 35 kD diheterodimer subunit bound to the disulfide of...
The interleukin 12A is a new signal cytokine belonging to the Interleukine-6 protein superfamily. The interleukin-12 alpha chain precursor (IL-12A) is a 35 kD diheterodimer subunit bound to IL-12 cytokine disulfide and has a wide range of biological activities. Reports suggest that the IL-12A can act as a growth factor for activated T and NK cells and improve the lytic activity of lymphokine-activated NK cells. The IL-12A stimulates the production of the IFN-gamma by resting PBMC as well as independent induction of interferon (IFN)-gamma T cells, and assists in differentiation of Th1 and Th2 cells. It is also involved in the positive regulation of tyrosine phosphorylation of Stat4 protein. The process of signalling the IL-12A in innate immunity requires the synthase of the nitric oxide 2A. With the EBI3, the IL-12A forms a new heterodimer cytokine, known as interleukin 35 (IL-35), which can be specifically produced by T reg cells and is required for maximum suppressive activity.
Sensitivity
Sensitivity of the dosage: 2.2 ng/ml.
Measurement range
Dose range: 2.458 to 600 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Coefficient of intradose variation < 10%, interdose < 12%.